Phase I evaluation of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C-alpha, in patients with advanced cancer (Q33330493)
scientific article
Language:
Current Data About Phase I evaluation of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C-alpha, in patients with advanced cancer
(P31) (Q13442814)
(P248)
(P698) 10550158
(P813) Tuesday, July 25, 2017

(P304) 3586-3595
(P248)
(P698) 10550158
(P813) Tuesday, July 25, 2017

(P407) (Q1860)

(P433) 11
(P248)
(P698) 10550158
(P813) Tuesday, July 25, 2017

(P478) 17
(P248)
(P698) 10550158
(P813) Tuesday, July 25, 2017

(P577) Monday, November 1, 1999
(P248)
(P698) 10550158
(P813) Tuesday, July 25, 2017

(P921) (Q181600)

(P1433) (Q400292)
(P248)
(P698) 10550158
(P813) Tuesday, July 25, 2017

(P1476) "Phase I evaluation of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C-alpha, in patients with advanced cancer" (language: en)
(P248)
(P698) 10550158
(P813) Tuesday, July 25, 2017

(P2093) J Nemunaitis
(P1545) 1
(P248)
(P698) 10550158
(P813) Tuesday, July 25, 2017

J T Holmlund
(P1545) 2
(P248)
(P698) 10550158
(P813) Tuesday, July 25, 2017

M Kraynak
(P1545) 3
(P248)
(P698) 10550158
(P813) Tuesday, July 25, 2017

D Richards
(P1545) 4
(P248)
(P698) 10550158
(P813) Tuesday, July 25, 2017

J Bruce
(P1545) 5
(P248)
(P698) 10550158
(P813) Tuesday, July 25, 2017

N Ognoskie
(P1545) 6
(P248)
(P698) 10550158
(P813) Tuesday, July 25, 2017

T J Kwoh
(P1545) 7
(P248)
(P698) 10550158
(P813) Tuesday, July 25, 2017

R Geary
(P1545) 8
(P248)
(P698) 10550158
(P813) Tuesday, July 25, 2017

A Dorr
(P1545) 9
(P248)
(P698) 10550158
(P813) Tuesday, July 25, 2017

D Von Hoff
(P1545) 10
(P248)
(P698) 10550158
(P813) Tuesday, July 25, 2017

S G Eckhardt
(P1545) 11
(P248)
(P698) 10550158
(P813) Tuesday, July 25, 2017

other details
description scientific article

External Links
(P356) 10.1200/JCO.1999.17.11.3586
(P698) 10550158